APOLIPOPROTEIN-E EPSILON-4 ALLELE FREQUENCY IN PATIENTS WITH LEWY BODY DEMENTIA, ALZHEIMERS-DISEASE AND AGE-MATCHED CONTROLS

被引:78
作者
STCLAIR, D
NORRMAN, J
PERRY, R
YATES, C
WILCOCK, G
BROOKES, A
机构
[1] NEWCASTLE GEN HOSP,DEPT NEUROPATHOL,NEWCASTLE TYNE NE4 6BE,ENGLAND
[2] NEWCASTLE GEN HOSP,MRC,NEUROCHEM PATHOL UNIT,NEWCASTLE TYNE NE4 6BE,ENGLAND
[3] UNIV EDINBURGH,ROYAL EDINBURGH HOSP,MRC,BRAIN METAB UNIT,EDINBURGH EH10 5HF,SCOTLAND
[4] FRENCHAY HOSP,DEPT CARE ELDERLY,BRISTOL BS16 1LE,ENGLAND
基金
英国惠康基金;
关键词
APOLIPOPROTEIN E; LEWY BODY DEMENTIA; ALZHEIMERS DISEASE; GENOTYPE; POLYMERASE-CHAIN REACTION;
D O I
10.1016/0304-3940(94)90867-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Genotypes of apolipoprotein E (ApoE) were determined by polymerase-chain reaction (PCR) amplification and restriction-sizing of brain DNA from 39 cases of Lewy body dementia (LBD), 68 senile Alzheimer's disease (AD) patients and 47 neuropathologically validated non-demented controls. There was a 3-fold increase in the epsilon 4 allele frequency in both LBD and AD groups compared with controls. These results indicate that LBD and AD share the epsilon 4 allele of ApoE as a major risk factor for the development of disease and suggest a similarity in disease aetiology.
引用
收藏
页码:45 / 46
页数:2
相关论文
共 14 条
[1]   DIFFUSE LEWY BODY DISEASE - CLINICAL-FEATURES IN 15 CASES [J].
BYRNE, EJ ;
LENNOX, G ;
LOWE, J ;
GODWINAUSTEN, RB .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (06) :709-717
[2]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[3]  
CUMMING AM, 1984, CLIN GENET, V25, P310
[4]   DIFFUSE LEWY BODY DISEASE - LIGHT AND ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY OF SENILE PLAQUES [J].
DICKSON, DW ;
CRYSTAL, H ;
MATTIACE, LA ;
KRESS, Y ;
SCHWAGERL, A ;
KSIEZAKREDING, H ;
DAVIES, P ;
YEN, SHC .
ACTA NEUROPATHOLOGICA, 1989, 78 (06) :572-584
[5]  
HANSEN L, 1990, NEUROLOGY, V40, P1
[6]   COMPARISON OF MODIFIED BIELSCHOWSKY SILVER IMPREGNATION AND ANTIUBIQUITIN IMMUNOSTAINING OF CORTICAL AND NIGRAL LEWY BODIES [J].
LOVE, S ;
NICOLL, JAR .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1992, 18 (06) :585-592
[7]   UBIQUITIN CARBOXYL-TERMINAL HYDROLASE (PGP 9.5) IS SELECTIVELY PRESENT IN UBIQUITINATED INCLUSION-BODIES CHARACTERISTIC OF HUMAN NEURODEGENERATIVE DISEASES [J].
LOWE, J ;
MCDERMOTT, H ;
LANDON, M ;
MAYER, RJ ;
WILKINSON, KD .
JOURNAL OF PATHOLOGY, 1990, 161 (02) :153-160
[8]   DEMENTIA WITH BETA-AMYLOID DEPOSITION - INVOLVEMENT OF ALPHA-B-CRYSTALLIN SUPPORTS 2 MAIN DISEASES [J].
LOWE, J ;
LANDON, M ;
PIKE, I ;
SPENDLOVE, I ;
MCDERMOTT, H ;
MAYER, RJ .
LANCET, 1990, 336 (8713) :515-516
[9]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[10]  
Perry R H, 1989, Lancet, V1, P166